Avandia
is a drug approved to treat Type 2 diabetes. Safety data from recent studies
indicated a potentially significant increase in the risk of heart attack and
heart-related deaths on patients taking Avandia. Avandia was approved in 1999
for the treatment of Type 2 diabetes, a serious and life-threatening disease
that affects 18 to 20 million Americans. The FDA updated the product's label in
2006 to include a new warning about a potential increase in heart attacks and
heart-related chest pain in some individuals using Avandia. Avandia is
manufactured by GlaxoSmithKline, which is based in Research Triangle Park in
North Carolina.
Contact Us
Davis & Feder P.A. is now handling claims for individuals who have suffered a
heart attack or heart-related death while taking Avandia. Davis & Feder P.A.
is experienced in pharmaceutical product liability cases and settlements.
If you or a loved one has suffered a heart attack or heart-related death while
taking Avandia, please contact us at 1-866-857-8500, or send us an email at
info@markdavispc.com.
Avandia
is a drug approved to treat Type 2 diabetes. Safety data from recent studies
indicated a potentially significant increase in the risk of heart attack and
heart-related deaths on patients taking Avandia. Avandia was approved in 1999
for the treatment of Type 2 diabetes, a serious and life-threatening disease
that affects 18 to 20 million Americans. The FDA updated the product's label in
2006 to include a new warning about a potential increase in heart attacks and
heart-related chest pain in some individuals using Avandia. Avandia is
manufactured by GlaxoSmithKline, which is based in Research Triangle Park in
North Carolina.